Mr. Hood is a Managing Director and Founder of William Hood & Company, a differentiated industry-focused investment bank covering the Consumer, Food and Retail sectors.

Mr. Hood is well-known globally as a leading investment banker to the Consumer Products and Health & Wellness industries having led or been involved in many of the larger and better-known transactions including the sale of Bonafide Health to Pharmavite for $425 million, YouTheory to Jamieson, the sale of Metagenics to Gryphon, the sale of VÖOST to Procter & Gamble, the sale of a majority stake in Welly to Unilever, the sale of Jarrow to New Mountain Capital, the sale of Liquid I.V. to Unilever, the sale of Persona Nutrition to Nestlé, the sale of OLLY to Unilever, the sale of GNC’s Nutra manufacturing subsidiary to IVC, the sale of Atrium Innovations (Garden of Life) to Nestlé for $2.4 billion, the sale of The Nature’s Bounty Company from The Carlyle Group to KKR, the sale of U.K.-based Holland & Barrett to Letter1 Retail for $2.3 billion, the sale of Unipharm to Takeda, the sale of Iovate to Xiwang (China) for $850 million, the sale of Jamieson to CCMP, the sale of Santa Cruz Nutrition to RoundTable Healthcare Partners, the sale of Schiff Nutrition to Reckitt Benckiser for $1.4 billion, the sale of Avid Health (Lil’ Critters and Vitafusion) to Church & Dwight for $650 million, the purchase of Airborne by Schiff Nutrition and the sale of Emergen-C to Pfizer for $350 million, among others.

Prior to launching William Hood & Company, Mr. Hood spent 8 years as a Managing Director at Houlihan Lokey (HL) where he founded, built and led the firm’s Consumer Health and Wellness practice. Prior to joining HL, Mr. Hood spent 9 years at a highly specialized investment banking boutique, a firm he joined at inception and where he became a Partner focused on transactions in the Consumer industry. Mr. Hood began his career 25 years ago at PaineWebber Investment Banking in New York.

Widely regarded as an expert in the industry, Mr. Hood is frequently invited to speak about M&A at key Health and Wellness conferences including Expo West, Expo East, the NBJ Summit, Supply Side West and ACG. Mr. Hood is also a contributor to both industry and financial publications and has been published or quoted about industry trends and matters of M&A in the Wall Street Journal, Bloomberg News, WWD and Reuters among others. Mr. Hood serves on the Editorial Board of the Nutrition Business Journal.

Mr. Hood has a global network and travels frequently to Europe and Asia. He grew up in the U.K. and Hong Kong and holds a B.S. from Georgetown University.

Mr. Hood serves on the Board of Directors of Vitamin Angels, the Board of Trustees of Vitamin Angels U.K. and the Board of Greenwich Emergency Medical Services in Greenwich, CT.

Mr. Hood holds the following FINRA Registrations: Series 7, 24, 63 and 79.

‍